Particle.news
Cancer Treatment Cancer Immunotherapy Cancer Vaccines Checkpoint Inhibitors Cellular Immunotherapy Cytokine Therapy mRNA Technology Drug Treatments CAR-T Therapy CAR T Cell Therapy T Cell Therapy Infection Treatment Cost of Treatment Immune Modulation Cancer Immunology Cellular Therapies Biomarkers Autoimmune Diseases Immune Cells Cognitive Effects Vaccine Development Immune Response Enhancement Combination Therapy CAR-T Cell Therapy Clinical Trials Innate Immune System T-cell Therapy PD-1 Inhibition
Researchers have created a multi-neoantigen vaccine blueprint alongside de novo protein binders that achieved precise T cell–mediated melanoma cell killing in vitro, now advancing into animal safety studies.
